NCT01731431 Multicenter Randomized Trial of Non-inferiority Between Glyburide and Insulin for the Treatment of Gestational Diabetes Status COMPLETED Phase PHASE3
NCT01730196 Lifestyle Change to Prevent Diabetes Via African-American Churches Status COMPLETED Phase NA
NCT01730014 A Trial Investigating the Safety, Tolerability, and Distribution and Activity in the Body of NNC0148-0000-0287 Injected Under the Skin in Healthy Subjects and in Subjects With Type 1 Diabetes Status COMPLETED Phase PHASE1
NCT01729546 Evaluating System Accuracy of Blood Glucose Monitoring Systems for Self-testing in Managing Diabetes Mellitus Status COMPLETED Phase NA
NCT01728467 The Effects of RVX000222 on Glucose Metabolism in Individuals With Pre-diabetes Status COMPLETED Phase PHASE2
NCT01720446 Trial to Evaluate Cardiovascular and Other Long-term Outcomes With Semaglutide in Subjects With Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT01720303 Efficacy and Safety of Repaglinide Combined With Insulin in Type 2 Diabetes Status COMPLETED Phase PHASE4
NCT01720290 Comparison of Repaglinide and Metformin Administered Alone or in Combination in Type 2 Diabetes Status COMPLETED Phase PHASE4
NCT01715012 Study of ST266 in Diabetic Subjects With Deep Burns Managed With Skin Grafts Status TERMINATED Phase PHASE2
NCT01713530 A 26-week Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart BID and Insulin Degludec OD Plus Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin in Need of Treatment Intensification With Mealtime Insulin Status COMPLETED Phase PHASE3
NCT01709929 Safety of Insulin Detemir for the Treatment of Insulin Dependent Type 1 or Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE3
NCT01707160 Pharmacokinetics and Pharmacodynamics of Biphasic Insulin Aspart 30 in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT01707134 Safety and Efficacy of Insulin Aspart in Subjects With Type 1 Diabetes Status COMPLETED Phase PHASE3